Gout
Insulin resistance measure may be ‘simple and cost-effective’ gout prediction tool
U.S. adults with higher triglyceride glycemic index scores demonstrate a greater likelihood of developing gout, according to data published in the Journal of Health, Population and Nutrition.
All-cause mortality lower with use of allopurinol, febuxostat for adults on hemodialysis
Allopurinol and febuxostat were both associated with lower all-cause mortality when used by adults undergoing hemodialysis in Japan; allopurinol also lowered risk of death from CVD events, according to study data.
FDA approves new label for Gloperba enabling precision dosing for gout prophylaxis
The FDA has approved an updated label for Gloperba, an oral liquid colchicine formulation, allowing for precision dosing, according to a press release from Scilex Holding Company.
Gout cases estimated to increase more than 70% worldwide by 2050
The total number of patients with gout across the world is estimated to increase more than 70% from 2020 to 2050, largely due to aging and population growth, according to forecasting model data published in The Lancet Rheumatology.